A biotechnology company using placental mesenchymal stem cells to develop cell therapies for medical conditions such as inflammation, ischemia, hematological disorders, and radiation.
Pluristem sees positive signs in preliminary COVID-19 test
Michael Fitzhugh
https://www.bioworld.com/articles/434261-pluristem-sees-positive-signs-in-preliminary-covid-19-test
Web
April 7, 2020